Status:
COMPLETED
Effect of Remimazolam and Propofol on Hemodynamic Stability During Anesthesia Induction in OPCAB Patients
Lead Sponsor:
Seoul National University Hospital
Conditions:
Hemodynamic Instability
Eligibility:
All Genders
19+ years
Phase:
NA
Brief Summary
Remimazolam is a novel ultra-short-acting benzodiazepine. Several studies demonstrated that its efficacy as a sedative hypnotics for general anesthesia is non-inferior to propofol. However, evidence o...
Eligibility Criteria
Inclusion
- Adult patient (aged 19 years or older) who scheduled for elective coronary artery bypass grafting
Exclusion
- Patients who refuse to participate
- Concomitant heart valve surgery or thoracic aorta surgery
- Emergent surgery
- Preoperative sedation
- Intubated state
- Patients with mechanical circulatory assist device
- Preoperative use of inotropes or vasopressors
- History of allergy or adverse reaction to study drugs
- Rapid sequence intubation
- Lactose intolerance
- Peanut allergy
Key Trial Info
Start Date :
July 26 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 8 2023
Estimated Enrollment :
106 Patients enrolled
Trial Details
Trial ID
NCT05423951
Start Date
July 26 2022
End Date
November 8 2023
Last Update
November 22 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Seoul National University Hospital
Seoul, South Korea, 03080